Mayer on the Optimization of SERDs in ER+ Breast Cancer
Season 5, Episode 24, Jul 15, 2021, 06:46 PM
Dr. Mayer discusses the mechanism of action of SERDs in ER-positive breast cancer, highlighted data from the AMEERA-1 trial with amcenestrant and palbociclib, and details future research efforts with SERDs.